3 recruiting, 2 unknown, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Recruiting 3, Unknown 2, Active not recruiting 1, Enrolling by invitation 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Letrozole tablets: new trials by email Literature Review of Letrozole tablets trials Research Report on Letrozole tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer HRS-8080 Tablets, Letrozole tablets, Tamoxifen Citrate Tablets - Breast Cancer | Phase 3 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 5500 | 2026-03-04 | 2026-05-22 |
| A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer HRS-8080 Tablet, Fulvestrant injection, Exemestane tablets - Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 3 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 240 | 2025-07-23 | 2026-10-02 |
| Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study TOL2506, Tamoxifen, Letrozole tablets - Breast Cancer | Phase 3 | Enrolling by invitation | Tolmar Inc. | 250 | 2022-12-28 | 2026-10-23 |
| Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) Letrozole tablets, carboplatin AUC 5 and paclitaxel 175 mg/m2 - Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary | Phase 3 | Recruiting | Ente Ospedaliero Ospedali Galliera | 132 | 2022-09-22 | 2025-01-27 |
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer TOL2506, Tamoxifen, Letrozole Tablets - Breast Cancer | Phase 3 | Active not recruiting | Tolmar Inc. | 250 | 2021-07-01 | 2026-10-23 |
| Letrozole in Tubal Ectopic Pregnancy Placebos, Letrozole tablets - Tubal Pregnancy | Phase 3 | Unknown | Queen Mary Hospital, Hong Kong | 214 | 2020-12-01 | 2023-04-10 |
| Letrozole as a Prophylaxis From GTN for Complete Mole Patients Suction evacuation, Letrozole tablets - Gestational Trophoblastic Disease | Phase 2 / Phase 3 | Unknown | Zagazig University | 200 | 2020-06-01 | 2022-07-12 |
Breast Neoplasms (4) · Neoplasms (2) · Carcinoma, Ovarian Epithelial (1) · Gestational Trophoblastic Disease (1) · Hydatidiform Mole (1) · Pregnancy, Tubal (1)
Shandong Suncadia Medicine Co., Ltd. (2) · Tolmar Inc. (2) · Ente Ospedaliero Ospedali Galliera (1) · Queen Mary Hospital, Hong Kong (1) · Zagazig University (1)
Argentina (2) · Brazil (2) · China (2) · India (2) · Mexico (2) · Puerto Rico (2) · United States (2) · Canada (1) · Egypt (1) · Hong Kong (1) · Italy (1)
Andrea DeCensi, MD (1) · E P Hamilton (1) · Ernest H.Y. Ng, MD (1) · Mohamed A Alabiad, MD (1)